哎呀哎呀在线观看视频|狼狼鲁色在线视频播放|天天躁日日躁狠狠躁欧美老妇|波斯女人1977满天星|九阳真经未满十八岁能学吗|被老外做的都肿了|7tv影院

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Human Transcriptional enhancer factor TEF-5 (TEAD3), partial CSB-YP860344HU 1mg/100ug/20ug
Recombinant Human S-adenosylmethionine synthase isoform type-2 (MAT2A) CSB-YP013517HUa0 1mg/100ug/20ug
Recombinant Human Microtubule-associated protein tau (MAPT) CSB-YP013481HU(F8)L5 1mg/100ug/20ug
Recombinant Human Growth/differentiation factor 9 (GDF9) CSB-MP009352HU(A4) 1mg/100ug/20ug
Recombinant Mouse Heat shock 70 kDa protein 1-like (Hspa1l) CSB-YP010823MO 1mg/100ug/20ug
Recombinant Human Nucleosome assembly protein 1-like 1 (NAP1L1) CSB-YP015441HU 1mg/100ug/20ug
Recombinant Mouse Mucin-1 (Muc1),partial CSB-YP312543MO 1mg/100ug/20ug
Recombinant Human RNA-binding protein FXR1 (FXR1) CSB-YP009087HU(A4) 1mg/100ug/20ug
Recombinant Porcine reproductive and respiratory syndrome virus Glycoprotein 4 (GP4),partial CSB-YP368832PYZ1 1mg/100ug/20ug
Recombinant Human Netrin receptor UNC5C (UNC5C)(A150V),partial CSB-YP025630HU(F)(M) 1mg/100ug/20ug
Recombinant Mouse Biliverdin reductase A (Blvra) CSB-YP002721MO 1mg/100ug/20ug
Recombinant Mouse Receptor activity-modifying protein 3 (Ramp3), partial CSB-YP896247MO 1mg/100ug/20ug
Recombinant Bacteriophage H30 Shiga-like toxin 1 subunit B (stxB) CSB-YP303961BDK 1mg/100ug/20ug
Recombinant Human Cytotoxic granule associated RNA binding protein TIA1 (TIA1) CSB-YP023527HU 1mg/100ug/20ug
Recombinant Human Delta and Notch-like epidermal growth factor-related receptor (DNER), partial CSB-YP818784HU 1mg/100ug/20ug
Recombinant Human Eosinophil peroxidase (EPX) CSB-YP007756HU 1mg/100ug/20ug
Recombinant Mycobacterium intracellulare Lipoprotein LpqH(lpqH) CSB-MP333609MVM 1mg/100ug/20ug
Recombinant Human cytomegalovirus Enhanced green fluorescent protein (egfp) CSB-YP2069HIZ(M)p8 1mg/100ug/20ug
Recombinant Human Microtubule-associated protein tau(MAPT) CSB-MP013481HU(F8)L5 1mg/100ug/20ug
Recombinant Human Tumor necrosis factor receptor superfamily member 25 (TNFRSF25), partial CSB-MP839000HU 1mg/100ug/20ug

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×